Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Willard

Showing results (261-270 of 267) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 267 results.
Oncotarget|March 24, 2018
Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumorsBruce W Konicek, Andrew R Capen, Kelly M Credille, et al.
Scientific Reports|October 27, 2019
Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patientsSteven M Bray, Jeeyun Lee, Seung Tae Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2023
Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C Flint, Dana K Mitchell, Steven P Angus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2024
Correction: Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C Flint, Dana K Mitchell, Steven P Angus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 30, 2025
Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLCTimothy F Burns, Natraj Reddy Ammakkanavar, Antoine Hollebecque, et al.
Nature Communications|March 13, 2026
Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human studyYonina R Murciano-Goroff, Antoine Hollebecque, Rebecca S Heist, et al.
Genome Research|June 22, 2013
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinomaZhengyan Kan, Hancheng Zheng, Xiao Liu, et al.
Pageof 27

Showing results (261-270 of 267) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 267 results.
Oncotarget|March 24, 2018
Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumorsBruce W Konicek, Andrew R Capen, Kelly M Credille, et al.
Scientific Reports|October 27, 2019
Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patientsSteven M Bray, Jeeyun Lee, Seung Tae Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2023
Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C Flint, Dana K Mitchell, Steven P Angus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2024
Correction: Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C Flint, Dana K Mitchell, Steven P Angus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 30, 2025
Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLCTimothy F Burns, Natraj Reddy Ammakkanavar, Antoine Hollebecque, et al.
Nature Communications|March 13, 2026
Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human studyYonina R Murciano-Goroff, Antoine Hollebecque, Rebecca S Heist, et al.
Genome Research|June 22, 2013
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinomaZhengyan Kan, Hancheng Zheng, Xiao Liu, et al.
Pageof 27